Search research articles
Contact Us
Filters
Showing results (131-140 of 211) with videos related to
Page
of 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1987
Molecular markers of neuroendocrine development and evidence of environmental regulation
L J Helman, C J Thiele, W M Linehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Osteosarcoma: the same old drugs or more?
Stefan S Bielack, Neyssa Marina, Stefano Ferrari, et al.
Oncogene
|
October 15, 1998
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma
L Zhang, S Zhan, F Navid, et al.
Cancer Research
|
March 15, 1996
Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis
L Zhang, F Kashanchi, Q Zhan, et al.
Cancer Research
|
April 6, 2006
CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta
Masaki Terabe, Chand Khanna, Seuli Bose, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
April 13, 2012
Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer
H Schayek, I Bentov, J Jacob-Hirsch, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumors
M J Cooper, L J Helman, A E Evans, et al.
The Journal of Clinical Investigation
|
September 1, 1989
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II
O M El-Badry, J A Romanus, L J Helman, et al.
Oncogene
|
December 3, 2013
Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
Z Kang, Y Yu, Y J Zhu, et al.
Neoplasia (New York, N.Y.)
|
March 16, 2011
Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells
Patrick J Grohar, Laurie B Griffin, Choh Yeung, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 211) with videos related to
Sort By:
Page
of 22
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1987
Molecular markers of neuroendocrine development and evidence of environmental regulation
L J Helman, C J Thiele, W M Linehan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Osteosarcoma: the same old drugs or more?
Stefan S Bielack, Neyssa Marina, Stefano Ferrari, et al.
Oncogene
|
October 15, 1998
AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma
L Zhang, S Zhan, F Navid, et al.
Cancer Research
|
March 15, 1996
Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis
L Zhang, F Kashanchi, Q Zhan, et al.
Cancer Research
|
April 6, 2006
CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta
Masaki Terabe, Chand Khanna, Seuli Bose, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
April 13, 2012
Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer
H Schayek, I Bentov, J Jacob-Hirsch, et al.
Progress in Clinical and Biological Research
|
January 1, 1988
Chromogranin A expression in childhood peripheral neuroectodermal tumors
M J Cooper, L J Helman, A E Evans, et al.
The Journal of Clinical Investigation
|
September 1, 1989
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II
O M El-Badry, J A Romanus, L J Helman, et al.
Oncogene
|
December 3, 2013
Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
Z Kang, Y Yu, Y J Zhu, et al.
Neoplasia (New York, N.Y.)
|
March 16, 2011
Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells
Patrick J Grohar, Laurie B Griffin, Choh Yeung, et al.
Page
of 22